MCRB - Seres Therapeutics, Inc.
IEX Last Trade
0.9509
0 0%
Share volume: 44
Last Updated: Fri 27 Dec 2024 02:30:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$0.95
0.00
0.00%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-03 | 2022-11-02 | 2023-03-07 | 2023-05-09 | 2023-08-08 | 2023-11-02 | 2024-03-05 | 2024-05-08 | |
| Total revenue | 1.216 M | 3.444 M | 975.000 K | -522.000 K | 126.473 M | 310.000 K | 64.000 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.216 M | 3.444 M | 975.000 K | -522.000 K | 126.473 M | 310.000 K | 64.000 K | 0.000 | |
| 183.22% | -71.69% | -153.54% | 24,328.54% | -99.75% | -79.35% | -100.00% | |||
| Operating expenses | 64.270 M | 61.500 M | 68.624 M | 66.439 M | 74.843 M | 48.242 M | 44.080 M | 37.168 M | |
| Selling general and admin | 20.335 M | 18.384 M | 22.404 M | 22.470 M | 28.051 M | 19.989 M | 17.234 M | 15.466 M | |
| Research and development | 43.935 M | 43.116 M | 46.220 M | 43.969 M | 46.792 M | 28.253 M | 26.846 M | 21.702 M | |
| Total expenses | 64.270 M | 61.500 M | 69.628 M | 66.439 M | 76.949 M | 47.723 M | 43.197 M | 39.586 M | |
| -4.31% | 13.22% | -4.58% | 15.82% | -37.98% | -9.48% | -8.36% | |||
| Operating income | -63.054 M | -58.056 M | -68.653 M | -66.961 M | 49.524 M | -47.413 M | -43.133 M | -39.586 M | |
| Ebit | -63.325 M | -59.107 M | -68.307 M | -70.568 M | 49.524 M | -47.413 M | -39.526 M | -39.586 M | |
| Pretax income | -64.735 M | -60.002 M | -68.796 M | -71.174 M | 46.552 M | -47.854 M | -41.248 M | -40.133 M | |
| -7.31% | 14.66% | 3.46% | -165.41% | -202.80% | -13.80% | -2.70% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -64.735 M | -60.002 M | -68.796 M | -71.174 M | 46.552 M | -47.854 M | -41.248 M | -40.133 M | |
| 7.31% | -14.66% | -3.46% | 165.41% | -202.80% | 13.80% | 2.70% | |||
| Net income | -64.735 M | -60.002 M | -68.796 M | -71.174 M | 46.552 M | -47.854 M | -41.248 M | -40.133 M | |
| 7.31% | -14.66% | -3.46% | 165.41% | -202.80% | 13.80% | 2.70% |